MedTrace Logo

Evaluation of the Therapeutic Effect of Platelet Rich Plasma (PRP) in Periorbital Hyperpigmentation(POH)

NCT03862118 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-03-06

No results posted yet for this study

Summary

To evaluate the saftey and efficicacy of autologous PRP in treatment of POH.

Conditions

  • Periorbital Hypermelanosis

Interventions

OTHER

PRP

platelet rich plasma will be delivered by intradermal method using mestherapy needle.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • azza rady, doctor · Assuit university hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-11-01
Completion
2020-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03862118 on ClinicalTrials.gov